These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 26111521)

  • 1. Boosting BCG-primed mice with chimeric DNA vaccine HG856A induces potent multifunctional T cell responses and enhanced protection against Mycobacterium tuberculosis.
    Ji P; Hu ZD; Kang H; Yuan Q; Ma H; Wen HL; Wu J; Li ZM; Lowrie DB; Fan XY
    Immunol Res; 2016 Feb; 64(1):64-72. PubMed ID: 26111521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
    Li W; Li M; Deng G; Zhao L; Liu X; Wang Y
    Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of immunogenic effect of the BCG priming and Ag85A- GM-CSF boosting in Balb/c mice model.
    Dou J; Tang Q; Yu F; Yang H; Zhao F; Xu W; Wang J; Hu W; Hu K; Liou C; Feng He X; Wang Y
    Immunobiology; 2010; 215(2):133-42. PubMed ID: 19450898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved humoral immunity against tuberculosis ESAT-6 antigen by chimeric DNA prime and protein boost strategy.
    Li Z; Song D; Zhang H; He W; Fan X; Zhang Y; Huang J; Wang X; Liu Q; Xiong S
    DNA Cell Biol; 2006 Jan; 25(1):25-30. PubMed ID: 16405398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subunit vaccine candidate AMM down-regulated the regulatory T cells and enhanced the protective immunity of BCG on a suitable schedule.
    Luo Y; Jiang W; Da Z; Wang B; Hu L; Zhang Y; An R; Yu H; Sun H; Tang K; Tang Z; Wang Y; Jing T; Zhu B
    Scand J Immunol; 2012 Mar; 75(3):293-300. PubMed ID: 22117839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using a prime and pull approach, lentivector vaccines expressing Ag85A induce immunogenicity but fail to induce protection against Mycobacterium bovis bacillus Calmette-Guérin challenge in mice.
    Britton G; MacDonald DC; Brown JS; Collins MK; Goodman AL
    Immunology; 2015 Oct; 146(2):264-70. PubMed ID: 26095282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterologous Boost Following
    Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
    Front Immunol; 2018; 9():2439. PubMed ID: 30425711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prime-boost BCG vaccination with DNA vaccines based in β-defensin-2 and mycobacterial antigens ESAT6 or Ag85B improve protection in a tuberculosis experimental model.
    Cervantes-Villagrana AR; Hernández-Pando R; Biragyn A; Castañeda-Delgado J; Bodogai M; Martínez-Fierro M; Sada E; Trujillo V; Enciso-Moreno A; Rivas-Santiago B
    Vaccine; 2013 Jan; 31(4):676-84. PubMed ID: 23196205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against Mycobacterium tuberculosis challenge in mice by DNA vaccine Ag85A-ESAT-6-IL-21 priming and BCG boosting.
    Dou J; Wang Y; Yu F; Yang H; Wang J; He X; Xu W; Chen J; Hu K
    Int J Immunogenet; 2012 Apr; 39(2):183-90. PubMed ID: 22152009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Promising Listeria-Vectored Vaccine Induces Th1-Type Immune Responses and Confers Protection Against Tuberculosis.
    Yin Y; Lian K; Zhao D; Tao C; Chen X; Tan W; Wang X; Xu Z; Hu M; Rao Y; Zhou X; Pan Z; Zhang X; Jiao X
    Front Cell Infect Microbiol; 2017; 7():407. PubMed ID: 29034213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in mice.
    Xu Y; Yang E; Wang J; Li R; Li G; Liu G; Song N; Huang Q; Kong C; Wang H
    Immunology; 2014 Oct; 143(2):277-86. PubMed ID: 24773322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines.
    Hu Z; Jiang W; Gu L; Qiao D; Shu T; Lowrie DB; Lu SH; Fan XY
    J Mol Med (Berl); 2019 Dec; 97(12):1685-1694. PubMed ID: 31786669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal boosting with MVA encoding secreted mycobacterial proteins Ag85A and ESAT-6 generates strong pulmonary immune responses and protection against M. tuberculosis in mice given BCG as neonates.
    Khanna M; Rady H; Dai G; Ramsay AJ
    Vaccine; 2021 Mar; 39(12):1780-1787. PubMed ID: 33632562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A booster vaccine expressing a latency-associated antigen augments BCG induced immunity and confers enhanced protection against tuberculosis.
    Dey B; Jain R; Gupta UD; Katoch VM; Ramanathan VD; Tyagi AK
    PLoS One; 2011; 6(8):e23360. PubMed ID: 21858087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Profile of T Cell Responses in Bacille Calmette-Guérin-Primed Mice Boosted by a Novel Sendai Virus Vectored Anti-Tuberculosis Vaccine.
    Hu Z; Gu L; Li CL; Shu T; Lowrie DB; Fan XY
    Front Immunol; 2018; 9():1796. PubMed ID: 30123219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced protective efficacy against Mycobacterium tuberculosis afforded by BCG prime-DNA boost regimen in an early challenge mouse model is associated with increased splenic interleukin-2-producing CD4 T-cell frequency post-vaccination.
    Kang H; Yuan Q; Ma H; Hu ZD; Han DP; Wu K; Lowrie DB; Fan XY
    Immunology; 2014 Dec; 143(4):661-9. PubMed ID: 24965530
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Jia Q; Masleša-Galić S; Nava S; Horwitz MA
    mBio; 2022 Jun; 13(3):e0068722. PubMed ID: 35642945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC-restricted Ag85B-specific CD8
    Komine-Aizawa S; Jiang J; Mizuno S; Hayakawa S; Matsuo K; Boyd LF; Margulies DH; Honda M
    Eur J Immunol; 2019 Sep; 49(9):1399-1414. PubMed ID: 31135967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.